Copyright
©The Author(s) 2018.
World J Gastroenterol. Jul 7, 2018; 24(25): 2710-2721
Published online Jul 7, 2018. doi: 10.3748/wjg.v24.i25.2710
Published online Jul 7, 2018. doi: 10.3748/wjg.v24.i25.2710
Rat | Primary HCC | Implanted hepatic R1 | |||||||
Tumor code | CA4P-induced necrosis, % | Tumor diameter in mm | Tumor vascularity1 | Tumor differentiation2 | Tumor code | CA4P-induced necrosis, % | Tumor diameter in mm | Tumor vascularity1 | |
1 | HCC_1 | 21.8 | 9.7 | ++ | II | R1_1 | 72.3 | 12.1 | ++ |
HCC_2 | 16.4 | 6.5 | ++ | III-IV | |||||
HCC_3 | 0 | 10.9 | ++ | III | |||||
2 | HCC_4 | 43.1 | 6.4 | + | III | R1_2 | 84.5 | 12.6 | ++ |
HCC_5 | 23.3 | 8.5 | ++ | III | |||||
3 | HCC_6 | 92.3 | 8.1 | + | I-II | R1_3 | 99.2 | 10 | ++ |
HCC_7 | 96.5 | 6.2 | + | II | |||||
HCC_8 | 19.8 | 10 | + | I | |||||
HCC_9 | 98.9 | 10 | + | II | |||||
4 | HCC_10 | 99.2 | 14.3 | + | I-II | R1_4 | 96.8 | 9.8 | ++ |
5 | HCC_11 | 27.6 | 18.3 | + | III | R1_5 | 99.4 | 8.3 | ++ |
HCC_12 | 4.9 | 7.8 | ++ | II-III | |||||
HCC_13 | 62.7 | 13 | + | I-II | |||||
6 | HCC_14 | 47.6 | 14.2 | +, +++3 | I, III4 | R1_6 | 97.7 | 9 | ++ |
HCC_15 | 46.4 | 14.2 | +, +++3 | I, III4 | |||||
7 | HCC_16 | 76.1 | 12.5 | + | II-III | R1_7 | 98.3 | 6.2 | ++ |
HCC_17 | 552.6 | 11.9 | + | III | |||||
HCC_18 | 33.4 | 10.4 | + | III | |||||
HCC_19 | 91.2 | 9 | + | I-II | |||||
Mean ± SD | 50.2 ± 1.8 | 10.6 ± 0.2 | / | / | 92.6 ± 1.5 | 9.7 ± 0.3 | / |
- Citation: Liu YW, De Keyzer F, Feng YB, Chen F, Song SL, Swinnen J, Bormans G, Oyen R, Huang G, Ni YC. Intra-individual comparison of therapeutic responses to vascular disrupting agent CA4P between rodent primary and secondary liver cancers. World J Gastroenterol 2018; 24(25): 2710-2721
- URL: https://www.wjgnet.com/1007-9327/full/v24/i25/2710.htm
- DOI: https://dx.doi.org/10.3748/wjg.v24.i25.2710